A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NASH

Search Conditions:
Search Keyword : NASH
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NASH
Appearance Frequency: 4833 time(s)
Long forms: 37

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
nonalcoholic steatohepatitis
(4781 times)
Gastroenterology
(1762 times)
NAFLD (1995 times)
HCC (348 times)
MCD (258 times)
0 Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms.
NAFLD and steatohepatitis
(4 times)
General Surgery
(1 time)
NAFLD (4 times)
HYF (1 time)
INR (1 time)
2004 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
National Audit of Seizure management in Hospitals
(4 times)
Neurology
(1 time)
EDs (2 times)
2015 National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK.
non-alcoholic fatty liver disease
(3 times)
Medicine
(2 times)
4-HNE (1 time)
CA (1 time)
CV (1 time)
2014 Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data.
nonalcoholic hepatic steatosis and steatohepatitis
(3 times)
Pharmacology
(1 time)
NAFLD (2 times)
ER (1 time)
fabp3 (1 time)
2008 Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
nucleic acid spot hybridization
(3 times)
Biochemistry
(1 time)
PCR (2 times)
BBTD (1 time)
BBTV (1 time)
2009 Detection of Huanglongbing (citrus greening) disease by nucleic acid spot hybridization.
nearest accessible specialist hospital
(2 times)
Pulmonary Medicine
(1 time)
NSCLC (2 times)
2015 Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study.
non-alcoholic fatty liver disease and steatohepatitis
(2 times)
Gastroenterology
(1 time)
HFD (1 time)
HSC (1 time)
LPC (1 time)
2017 Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
non-alcoholic liver disease
(2 times)
Medicine
(1 time)
AI (1 time)
ALD (1 time)
HBV (1 time)
2006 [Non-alcoholic liver disease (NASH)].
10  nonalcoholic fatty liver disease
(2 times)
Biology
(1 time)
CD74 (1 time)
CI (1 time)
IQR (1 time)
2014 Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.
11  encompasses a spectrum from simple steatosis to steatohepatitis
(1 time)
Medicine
(1 time)
DEGs (1 time)
IPA (1 time)
NAFLD (1 time)
2017 Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
12  inflammation and steatohepatisis
(1 time)
Science
(1 time)
NAFLD (1 time)
2010 The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease.
13  NAFLD can progress to steatohepatitis
(1 time)
Medicine
(1 time)
MVs (1 time)
NAFLD (1 time)
2017 Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
14  NAFLD includes fatty liver alone or steatohepatitis
(1 time)
Anatomy
(1 time)
NAFD (1 time)
2002 The clinicopathologic spectrum and management of nonalcoholic fatty liver disease.
15  NAFLD progresses from benign steatosis to steatohepatitis
(1 time)
Biochemistry
(1 time)
ASOs (1 time)
FSP27 (1 time)
NAFLD (1 time)
2017 Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
16  NAFLD ranges from simple fatty liver to steatohepatitis
(1 time)
Pharmacology
(1 time)
HCC (1 time)
NAFLD (1 time)
2005 The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
17  NAFLD with inflammatory features
(1 time)
Food
(1 time)
BPF (1 time)
CAF (1 time)
IL-6 (1 time)
2018 Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity.
18  NAFLD, and its more severe form with steatohepatitis
(1 time)
Endocrinology
(1 time)
IR (1 time)
2014 High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
19  NAFLD, but can progress in some patients to advanced steatohepatitis
(1 time)
Gastroenterology
(1 time)
BIA (1 time)
CVD (1 time)
MS (1 time)
2016 Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk.
20  NAFLD, steatosis and steatohepatitis
(1 time)
Biochemistry
(1 time)
NAFLD (1 time)
2009 Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?
21  namely steatohepatitis
(1 time)
Gastroenterology
(1 time)
NAFLD (1 time)
2013 Nonalcoholic fatty liver disease in Asia: a story of growth.
22  NASH group
(1 time)
Diabetes Mellitus
(1 time)
FPG (1 time)
IFG (1 time)
NAFLD (1 time)
2011 Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.
23  NASH patients
(1 time)
Gastrointestinal Diseases
(1 time)
LP (1 time)
MTTs (1 time)
NAFLD (1 time)
2014 CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
24  NASH-HCC
(1 time)
Transplantation
(1 time)
HCC (1 time)
LT (1 time)
2018 Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
25  natural, accidental, suicidal, or homicidal
(1 time)
Health Services
(1 time)
HCP (1 time)
2017 Improving the support of the suddenly bereaved.
26  necroinflammatory steatohepatitis
(1 time)
Gastroenterology
(1 time)
CAD (1 time)
miRNAs (1 time)
NAFLD (1 time)
2016 Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
27  non-alcoholic hepatosteatosis
(1 time)
Fibrosis
(1 time)
HSCs (1 time)
2016 Activation of hepatic stellate cell in Pten null liver injury model.
28  non-Ashkenazi
(1 time)
Allergy and Immunology
(1 time)
AChR (1 time)
ASH (1 time)
MG (1 time)
2017 Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
29  non-invasive identification of steatohepatitis
(1 time)
Gastroenterology
(1 time)
ION (1 time)
LS (1 time)
NPV (1 time)
2018 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
30  non-invasive methods to detect steatohepatitis
(1 time)
Natural Science Disciplines
(1 time)
AUROC (1 time)
GE (1 time)
MR (1 time)
2016 Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
31  Non-linear Attentional Saturation Hypothesis
(1 time)
Nervous System Diseases
(1 time)
fMRI (1 time)
2018 Network Dynamics of Attention During a Naturalistic Behavioral Paradigm.
32  non-NASH
(1 time)
General Surgery
(1 time)
BMI (1 time)
HCV (1 time)
2019 Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.
33  nonalcoholic fatty liver diseases and more advanced steatohepatitis
(1 time)
Cell Biology
(1 time)
DKO (1 time)
Prdx4 (1 time)
SOD1 (1 time)
2018 Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure.
34  nonalcoholic hepatitis
(1 time)
Cell Biology
(1 time)
NAFLD (1 time)
2017 Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
35  Norwegian summer-autumn spawning herring
(1 time)
Science
(1 time)
NSAH (1 time)
NSSH (1 time)
2017 Oogenesis and reproductive investment of Atlantic herring are functions of not only present but long-ago environmental influences as well.
36  Nutrition and Activity Self-History
(1 time)
Obesity
(1 time)
ReCAP (1 time)
WIC (1 time)
2013 Innovative tools help counselors discuss childhood obesity with parents.
37  only a small proportion of these patients develop steatohepatitis
(1 time)
Gastroenterology
(1 time)
Hh (1 time)
2012 Mechanisms of disease progression in NASH: new paradigms.